Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.45 |
| ▸ | RAB9A | P51151 | 2/20 | 0.44 |
| ▸ | MEN1 | O00255 | 1/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.44 |
| ▸ | NPC1 | O15118 | 2/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.40 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.37 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.35 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.34 |
| ▸ | ATM | Q13315 | 1/20 | 0.32 |
| ▸ | HTT | P42858 | 1/20 | 0.32 |
| ▸ | LMNA | P02545 | 1/20 | 0.32 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.32 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23421827 | 0.94 | SMN1; SMN2 (0.41) | SMN1; SMN2RAB9AMEN1KMT2ANPC1 | |
| SCHEMBL23422043 | 0.91 | SMN1; SMN2 (0.40) | SMN1; SMN2RAB9AMEN1KMT2ANPC1 | |
| SCHEMBL29952967 | 0.85 | SMN1; SMN2 (0.46) | SMN1; SMN2RAB9AMEN1KMT2ANPC1 | |
| SCHEMBL10579577 | 0.75 | SMN1; SMN2 (0.52) | SMN1; SMN2RAB9AMEN1KMT2ANPC1 | |
| SCHEMBL23422001 | 0.75 | SMN1; SMN2 (0.41) | SMN1; SMN2RAB9AMEN1KMT2ANPC1 | |
| SCHEMBL6344541 | 0.74 | SMN1; SMN2 (0.48) | SMN1; SMN2RAB9AMEN1KMT2ANPC1 | |
| SCHEMBL8700542 | 0.74 | SMN1; SMN2 (0.48) | SMN1; SMN2RAB9AMEN1KMT2ANPC1 | |
| SCHEMBL2228123 | 0.74 | SMN1; SMN2 (0.48) | SMN1; SMN2RAB9AMEN1KMT2ANPC1 | |
| SCHEMBL8081105 | 0.74 | SMN1; SMN2 (0.48) | SMN1; SMN2RAB9AMEN1KMT2ANPC1 | |
| SCHEMBL21879877 | 0.73 | HTT (0.47) | SMN1; SMN2RAB9AMEN1KMT2ANPC1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12479834-B2 | Phenol compound or salt thereof | TAIHO PHARMACEUTICAL CO., LTD. (JP) | 2025-11-25 | — | — | US | disclosed |
| US-20230049402-A1 | NOVEL PHENOL COMPOUND OR SALT THEREOF | TAIHO PHARMACEUTICAL CO. LTD. (JP) | 2023-02-16 | — | — | US | disclosed |
| EP-4067343-A1 | NOVEL PHENOL COMPOUND OR SALT THEREOF | Taiho Pharmaceutical Co., Ltd. (JP) | 2022-10-05 | — | — | EP | disclosed |
| WO-2021106230-A1 | NOVEL PHENOL COMPOUND OR SALT THEREOF | 大鵬薬品工業株式会社 | 2021-06-03 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12479834-B2 | Phenol compound or salt thereof | REN, MLX, MYB | SMN1; SMN2 3261/4885RAB9A 876/4885MEN1 2667/4885 |
| US-20230049402-A1 | NOVEL PHENOL COMPOUND OR SALT THEREOF | MYB, MLX, EP300 | SMN1; SMN2 3158/4885RAB9A 919/4885MEN1 3722/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.